Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q1 2026 Earnings Call Transcript May 6, 2026
Operator: Greetings, and welcome to Rigel Pharmaceuticals Financial Conference call for the first quarter 2026. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce our speaker, Ray Furey, Rigel’s Executive Vice President, General Counsel and Corporate Secretary. Thank you. Mr. Furey, you may begin.
Raymond Furey: Welcome to our first quarter 2026...
